The normal intestinal mucosa: A state of 'controlled inflammation'

Inflammatory Bowel Disease: From Bench to Bedside

Volumn , Issue , 2006, Pages 101-120

  Fiocchi, Claudio ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891447998     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25808-6_5     Document Type: Chapter

References (145)

1. Brandtzaeg P, Farstad IN, Haraldsen G. Regional specialization in the mucosal immune system: Primed cells do not always home along the same track. Immunol Today 1999; 20: 267-77
2. Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee Jr. Mucosal Immunology, 2nd edn. San Diego: Academic Press, 1999
3. Mayer EA, Raybould H, Koelbel C. Neuropeptides, inflammation and motility. Dig Dis Sci 1988; 33: 71S-7S.
4. Chang S-K, Dohrman AF, Basbaum CB et al Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 1994; 107: 28-36
5. Cone RA, Mucus. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunity, 2nd edn. San Diego: Academic Press, 1999: 43-64
6. Kato T, Owen RL. Structure and function of intestinal mucosal epithelium. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunity, 2nd edn. San Diego: Academic Press, 1999: 115-32
7. Gebert A, Rothkotter HJ, Pabst R. M cells in Peyer's patches of the intestine. Int Rev Cytol 1996; 167: 91-159
8. Hecht G. Innate mechanisms of epithelial host defense: Spothght on intestine. Am J Physiol 1999; 277: C351-68
9. McKay DM, Baird AW. Cytokine regulation of epithelial permeability and ion transport. Gut 1999; 44: 283-9
10. Jung HC, Eckmann L, Yang S-K, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55-65
11. Kagnoff MF, Eckmann L. Epithehal cells as sensors for microbial infection. J Clin Invest 1997; 100: 6-10
12. Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF. Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 1998; 102: 1815-23
13. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells-polarity and complexity. Immunol Today 2000; 21: 123-8
14. Mayer L, Shlien R. Evidence for function of la molecules on gut epithehal cells in man. J Exp Med 1987; 166: 1471-83
15. Madara JL. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: Physiological rearrangements of tight junctions. J Membr Biol 1990; 116: 177-84
16. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995; 108: 1566-81
17. Soderholm JA, Peterson KM, Olaison G et al. Epithelial permeability to proteins in the noninflamed ileum of crohn's disease? Gastroenterology 1999; 117: 65-72
18. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-6
19. Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol 1992; 149: 2816-22
20. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-14
21. Akbar AN, Salmon M. Cellular environments and apoptosis: Tissue microenvironments control activated T cell death. Immunol Today 1997; 18: 72-6
22. Frenette PS, Wagner DD. Adhesion molecules-Part I. N Engl J Med 1996; 334: 1526-9
23. Panes J, Granger DN. Leukocyte-endothelial interactions: Molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 1998; 114: 1066-90
24. Briskin M, Winsor-Hines D, Shyjan A et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997; 151: 97-110
25. Salmi M, Jalkanen S. Molecules controlling lymphocyte migration to the gut. Gut 1999; 45: 148-53
26. Kunkel SL. Through the looking glass: The diverse in vivo activities of chemokines. J Chn Invest 1999; 104: 1333-4
27. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-102
28. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45
29. Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med 1998; 188:1751-6
30. Premack BA, Schall TJ. Chemokine receptors: Gateways to inflammation and infection. Nature Med 1996; 2: 1174-8
31. Ward SG, Bacon K, Westwick J. Chemokines and Tlymphocytes: More than an attraction. Immunity 1998; 9: 1-11
32. Campbell JJ, Haraldson G, Pan J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memeory T cells. Nature 1999; 400: 776-80
33. Mackay CR. Dual personality of memory T cells. Nature 1999;401:659-60
34. Zabel BA, Agace WA, Campbell JJ et al. Human G proteincoupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 1999; 190: 1241-55
35. Papadakis KA, Prehn J, Nelson V et al. The role of thymusexpressed chemokine and its receptor CCR9 in the regional specialization of the mucosal immune system. J Immunol 2000; 165: 5069-76
36. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med 1998;187: 129-34
37. Agace WW, Roberts Al, Wu L, Greineder C, Ebert EC, Parker CM. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemo kines induced by inflammation. Eur J Immunol 2000; 30: 819-26
38. Salmi M, Granfors K, MacDermott RP, Jalkanen S. Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel disease. Gastroenterology 1994; 106: 596-605
39. MacDermott RP, Sanderson IR, Reinecker H-C. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and crohn's disease. Inflamm Bowel Dis 1998; 4: 54-67
40. Selsted ME, Oullette AJ. Defensins in granules of phagocytic and phagocytic cells. Trends Cell Biol 1995; 5: 114-19
41. Ouellette A J. Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 1997; 113: 1779-84
42. Lehrer RI, Bevins CL, Ganz T. Defensins and other antimicrobial peptides. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunity, 2nd edn. San Diego: Academic Press, 1999: 89-99
43. Yang D, Chertov O, Bykovskaia SN et al. P-Defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525-8
44. Tomita M, Takase M, Bellamy W, Shimamura S. A review: The active peptide of lactoferrin. Acta Paediatr Jpn 1994; 36: 585-91
45. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-3
46. Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000;343: 338-44
47. Medzhitov R, Janeway CA. Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4-9
48. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Dwsophila JoW. Proc Natl Acad Sci USA 1998; 95: 588-93
49. Selby WS, Poulter LW, Hobbs S, Jewell D, Janossy G. Heterogeneity of HLA-DR positive histiocytes of human intestinal lamina propria: A combined histochemical and immunological analysis. J Clin Pathol 1983; 36: 379-84
50. Allison MC, Cornwall S, Poulter LW, Dhillon AP, Pounder RE. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 1988; 29: 1531-8
51. Hara J, Ohtani H, Matsumoto T et al. Expression of costimulatory molecules B7-1 anf B7-1 in macrophages and granulomas of crohn's disease: Demonstration of cellto-cell contact with T lymphocytes. Lab Invest 1997; 77: 175-84
52. Golder JP, Doe WF. Isolation and preliminary characterization of human intestinal macrophages. Gastroenterology 1983;84:795-802
53. Mahida YR, Wu KC, Jewell DP. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 1989; 30: 1362-70
54. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 1997; 112: 1493-505
55. Abbas AK, Lichtman AH, Pober JS, editors. Cellular and Molecular Immunology, 4th edn. Philadelphia: W.B. Saunders, 2000
56. Simmonds NJ, Allen RE, Stevens TRJ et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992; 103: 186-96
57. Oshitani N, Kitano A, Okabe H, Nakamura S, Matsumoto T, Kobayashi K. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut 1993; 34: 936-8
58. Buffington GD, Doe WF. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radical Biol Med 1995; 19:911-18
59. Dijkstra G, Moshage H, VanDulleman HM et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998; 186:416-21
60. Singer II, Kawka DW, Scott S et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-85
61. Wallace JL, Miller MJS. Nitric oxide in mucosal defense: A little goes a long way. Gastroenterology 2000; 119: 512-20
62. Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998; 16: 545-68
63. Halstensen TS, Mollnes TE, Brandtzaeg P. Persistent complement activation in submucosal vessels of active inflammatory bowel disease: Immunohistochemical evidence. Gastroenterology 1989; 97: 10-19
64. Ahrenstedt O, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hallgren R. Enhanced local production of complement components in the small intestines of patients with crohn's disease. N Engl J Med 1990; 322: 1345-9
65. Russell MW, Kilian M, Lamm ME. Biological activities of IgA. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunology, 2nd edn. San Diego: Academic Press, 1999
66. Carbonare SB, Silva MLM, Trabulsi LR, Carneiro-Sampaio MMS. Inhibition o-HEp-2 cell invasion by entroinvasive Escherichia coli by human colostrum IgA. Int Arch Allergy Immunol 1995; 198: 113-18
67. Childers NK, Bruce MG, McGhee Jr. Molecular mechanisms of immunoglobulin A defense. Annu Rev Microbiol 1989; 43: 503-36
68. Walker WA, Issclbacher KJ, Bloch KJ. Intestinal uptake of macromolecules: Effect of oral immunization. Science 1972; 177:608-10
69. Nikolova EB, Tomana M, Russell MW. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone. Scand J Immunol 1994; 39: 275-80
70. VanKerckhove C, Russell GJ, Deusch K et al. Oligoclonality of human intestinal intraepithelial T cells. J Exp Med 1992; 175: 57-63
71. Gross GC, Schwartz VL, Stevens C, Ebert EC, Blumberg RS, Balk SP Distribution of dominant T cell receptor P chain in human intestinal mucosa. J Exp Med 1994; 180: 1337-44
72. Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SH. Protective role of Y/5 T cells and a/p T cells in tuberculosis. Eur J Immunol 1995; 25: 2877-81
73. Ebert EC. Proliferative responses of human intraepithelial lymphocytes to various T cell stimuli. Gastroenterology 1989; 97: 1372-81
74. Cerf-Bensussan N, Guy-Grand D, Griscelli C. Intraepithelial lymphocytes of human gut: Isolation, characterization and study of natural killer activity. Gut 1985; 26: 81-8
75. Taunk J, Roberts Al, Ebert EC. Spontaneous cytotoxicity of human intrapithelial lymphocytes against epithelial cell tumors. Gastroenterology 1992; 102: 69-75
76. Ebert EC. Human intestinal intraepithelial lymphocytes have potent chemotactic activity. Gastroenterology 1996; 109: 1154-9
77. James SP, Fiocchi C, Graeff AS, Strober W. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T cell phenotype and deficiency of suppressor-inducer phenotype in crohn's disease and control patients. Gastroenterology 1986; 91: 1483-9
78. Saubermann LJ, Probert CSJ, Christ AD et al. Evidence of T cell receptor p-chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol 1999; 276: G613-21
79. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987; 28: 745-53
80. Matsuura T, West GA, Youngman KR, Klein JS, Fiocchi C. Immune activation genes in inflammatory bowel disease. Gastroenterology 1993; 104: 448-58
81. DeMaria R, Boirivant M, Cifone MG et al. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. J Clin Invest 1996; 97: 316-22
82. Boirivant M, Pica R, DeMaria R, Testi R, Paflone F, Strober W. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Chn Invest 1996; 98: 2616-22
83. Ina K, Itoh J, Fukushima K et al. Resistance of crohn's disease T cells to multiple apoptotic stimuli is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999; 163: 1081-90
84. Boirivant M, Marini M, DiFelice G et al. Lamina propria T cells in crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116: 557-65
85. Fiocchi C, Battisto JR, Farmer RG. Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus areus and lipopolysaccharides. Dig Dis Sci 1981;26:728-36
86. MacDermott RP, Franklin GO, Jenkins KM, Kodner IJ, Nash GS, Weinrieb IJ. Human intestinal mononuclear cells. I. Investigation of antibody-dependent, Lectin-induced, and spontaneous cell-mediated cytotoxic capabilities. Gastroenterology 1980; 78: 47-56
87. Fiocchi C, Tubbs RR, Youngman KR. Human intestinal mucosal mononuclear cells exhibit lymphokine-Activated killer ceU activity. Gastroenterology 1985; 88: 625-37
88. Shanahan S, Brogan M, Targan S. Human mucosal cytotoxic effector cells. Gastroenterology 1987; 92: 1951-7
89. MacDermott RP, Bragdon MJ, Jenkins KM, Franklin GO, Shedlofsky S, Kodner IJ. Human intestinal mononuclear cells. II. Demonstration of a naturally occurring subclass of T cells which respond in the allogeneic mixed lymphocyte reaction but do not effect cell-mediated lympholysis. Gastroenterology 1981; 80: 748-57
90. Fiocchi C. Cytokines. In: Targan SR, Shanahan F, editors. Inflammatory Bowel Disease. From Bench to Bedside. Baltimore: Williams & Wilkins, 1994: 106-22
91. Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria lymphokine secretion profiles in inflammatory bowel disease. J Immunol 1996; 157: 1261-70
92. Pirzer UC, Schurmann G, Post S, Betzler M, Meuer SC. Differential responsiveness to CD3-Ti vs CD2-dependent activation of human intestinal lymphocytes. Eur J Immunol 1990; 20: 2339-42
93. Qiao L, Schurmann G, Betzler M, Meuer SC. Activation and signaling status of human lamina propria T lymphocytes. Gastroenterology 1991; 101: 1529-36
94. Qiao L, Schurmann G, Betzler M, Meuer SC. Downregulation of protein kinase C activation in human lamina propria T lymphocytes: Influence of intestinal mucosa on T cell reactivity. Eur J Immunol 1991; 21: 2385-9
95. Qiao L, Schurmann G, Autschbach F, Wallich R, Meuer SC. Human intestinal mucosa alters T cell reactivities. Gastroenterology 1993; 105: 814-19
96. Meuer SC, Autschbach F, Schurmann G, Golling M, Braunstein J, Qiao L. Molecular mechanisms securing unresponsiveness' in lamina propria T lymphocytes. NY Acad Sci 1996; 778: 174-84
97. Bell GM, Imboden JB. CD2 and the regulation of T cell anergy. J Immunol 1995; 154: 2805-6
98. Quill H. Anergy as a mechanims of peripheral T cell tolerance. J Immunol 1996; 156: 1325-7
99. Zeitz M, Quinn TC, Graeff AS, James SP. Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in nonhuman primates. Gastroenterology 1988; 94: 353-66
100. McGhee JR, Lamm ME, Strober W. Mucosal immune responses. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunity,2nd edn. San Diego: Academic Press, 1999: 485-506
101. VanParijs L, Abbas AK. Homeostasis and self-Tolerance in the immune system: Turning lymphocytes off. Science 1998; 280: 243-8
102. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997; 158: 1989-93
103. Salojin KV, Zhang J, Madrenas J, Delovitch XL. T cell anergy and altered T cell receptor signaling: Effects on autoimmune disease. Immunol Today 1998; 19: 468-73
104. Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infections and autoimmune diseases. N Engl J Med 1996; 335: 1369-77
105. Marelli-Berg FM, Lechler RI. Antigen presentation by parenchymal cells: A route to peripheral tolerance? Immunol Rev 1999; 172:297-314
106. Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral blood T lymphocytes. Immunol Today 1993; 14: 338-9
107. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995;16:569-74
108. Shevach EA. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000; 18:423-49
109. Strobel S, Mowat AM. Immune responses to dietary antigens: Oral tolerance. Immunol Today 1998; 19: 173-81
110. Podolsky DK, Fiocchi C. Cytokines, chemokines, growth factors, eicosanoids and other bioactive molecules in IBD. In: Kirsner JB, editor. Inflammatory Bowel Disease. Philadelphia: WB. Saunders, 1999: 191-207
111. Husby S. Normal immune responses to ingested foods. J Pediatr Gastroenterol Nutr 2000; 30: SI3-19
112. Simecka JW. Mucosal immunity of the gastrointestinal tract and oral tolerance. Adv Drug Deliv Rev 1998; 34: 235-59
113. Whitaker CC, Gienapp IE, Orosz CG, Bitar D. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991; 147: 2155-63
114. Chen Y, Inobe J-I, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Science 1995; 376: 177-80
115. Saoudi A, Seddon B, Heath V, Fowell D, Mason D. The physiological role of regulatory T cells in the prevention of autoimmunity: The function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 1996; 149: 195-216
116. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-40
117. Groux H, O'Garra A, Bigler M et al. A CD4'-T ceU subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997; 389: 737-42
118. Khoo UY, Proctor IE, Macpherson AJS. CD4-T cell down-regulation in human intestinal mucosa. Evidence for intestinal tolerance to luminal bacterial antigens. J Immunol 1997; 158:3626-34
119. Cong BY, Brandwein SL, McCabe RP et al CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. J Exp Med 1998; 187: 855-64
120. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302
121. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995-1003
122. Gorelik L, Flavell RA. Abrogation of TGF(3 signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000; 12: 171-81
123. Weiner HL. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18: 335-43
124. Crowe SE. Food allergies. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal Immunity, 2nd edn. San Diego: Academic Press, 1999: 1129-39
125. Fiocchi C. The immunological resources of the large bowel. In: Kirsner JB, Shorter RG, editors. Diseases of the Colon, Rectum, and Anal Canal. Baltimore: Williams & Wilkins, 1988:95-117
126. Fuller R. A review: Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365-78
127. Kolb H, Pozzilli P. Cow's milk and type I diabetes: The gut immune system deserves attention. Immunol Today 1999; 20: 108-110
128. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Critical Rev Food Sci Nutr 1999; 38: 13-126
129. Wilson KH, Ikeda JS, Blitchington RB. Phylogenetic placement of community members in human colonic biota. Clin Infect Dis 1997; 25: SI 14-16
130. Famularo G, Moretti S, Marcellini S, DeSimone C. Stimulation of immunity by probiotics. In: Fuller R, editor. Probiotics 2. Applications and Practical Aspects. London: Chapman & Hall, 1997: 133-61
131. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109: 1344-67
132. Rath HC, Herfarth HH, Ikeda JS et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human p2 microglobulin transgenic rats. J Clin Invest 1996; 98: 945-53
133. Rath HC, Ikeda JS, Linde H-J, Scholmerich J, Wilson KH, Sartor RB. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1999; 116:310-19
134. Sellon RK, Tonkonogy S, Schultz M et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66: 5224-31
135. Rutgeerts P, Geboes K, Peeters M et al. Effect of faecal stream diversion on recurrence of crohn's disease in the neoterminal ileum. Lancet 1991; 2: 771-4
136. D'Haens G, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions caused by infusion of intestinal contents in excluded ileum of crohn's disease. Gastroenterology 1998; 114:262-7
137. Ruseler-Van-Embden JGH, Schouten WR, van Lieshout LMC. Pouchitis: Result of microbial imbalance? Gut 1994; 35: 658-64
138. Prantera C, Scribano ML, Berto E, Zannoni F. Antibiotic use in crohn's disease-why and how? Biodrugs 1997; 8: 293-306
139. Turunen UM, Farkkila MA, Hakala K et al. Long-Term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study. Gastroenterology 1998; 115: 1072-8
140. Gionchelti P, Rizzello F, Venturi A et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9
141. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer Zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but it is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-55
142. Duchmann R, Schmitt E, Knolle P, Meyer Zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interlukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26: 934-8
143. Pirzer U, Schonhaar A, Fleischer B, Hermann E, Meyer Zum Buschenfelde KH. Reactivity of infiltrating T lymphocytes with microbial antigens in crohn's disease. Lancet 1991:338: 1238-9
144. Takahashi I, Lijima H, Katashima R, Itakura M, Kiyono H. Clonal expansion of CD4-T cells in TCR a-chain-deficient mice by gut-derived antigens. J Immunol 1999; 162: 1843-50
145. Wirtz S, Finotto S, Kanzler S et al. Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF-plus IFN-yproducing CD4+ T cells that respond to bacterial antigens. J Immunol 1999; 162: 1884-8